ER Targeted PET with 18F-Fluoroestradiol (Cerianna):  Applications and Interpretation
Sponsored by the ACNM

Organizer
Gary Ulaner, MD, PhD, FACNM; Katherine Zukotynski, BASc, MD, PhD, P.Eng; Twyla Bartel, DO, MBA, FACNM, FSNMMI 

Moderator
Ashwin Parihar, MBBS, MD       

Speaker
Gary Ulaner, MD, PhD, FACNM

Hoag Family Cancer Institute

Course Summary
Fluoroestradiol (Cerianna) PET has been FDA approved for patients with breast cancer.  This webinar will review the clinical applications and interpretation of Fluoroestradiol PET.  The target audience will be  nuclear medicine physicians and radiologists.  The course would provide expertise in the proper application and interpretation of Fluoroestradiol PET for webinar attendees.  The expected outcomes are that attendees will better understand Fluoroestradiol PET and will be able to apply it more appropriately and effectively in their clinics.

Course Objectives

1. Understand the basic mechanism of Fluoroestradiol PET

2. Discuss appropriate clinical indications for Fluoroestradiol PET

3. Improve interpretation of Fluoroestradiol PET

CE Information
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.